OVER $1.6 MILLION
FOR
PATIENT CARE,
RESEARCH, EDUCATION, AND PREVENTION
Nearly 500 Guests Attend Event to Honor Richard L.
Shapiro, MD, Associate Professor of Surgery; Director,
Surgical Oncology Operations at The Cancer Institute
New York, NY —The
Cancer Institute at NYU Langone Medical Center, an NCI-designated
cancer center, raised
over $1.6 million at its annual gala held Thursday,
October 18. The event took place at The Plaza Hotel in
Manhattan and honored Richard
L. Shapiro, MD, associate
professor of surgery, director, Surgical Oncology
Operations at The
Cancer Institute, who specializes in breast cancer
and melanoma.
Each year, the NYU Cancer Institute Gala is held to
celebrate the dedication of its physicians, scientists,
nurses and other medical staff. Funds
raised support The Cancer
Institute’s continued
excellence in patient care, research, education, and
prevention, under the leadership of its director William
Carroll, MD, the
Julie and Edward J. Minskoff Professor of Pediatrics.
After welcoming and expressing his gratitude to the
gala’s nearly 500 guests, Robert
I. Grossman, MD, the
Saul J. Farber Dean and CEO of NYU Langone Medical
Center, acknowledged this year’s honoree, Dr. Shapiro,
by saying, “Richard is one of those physicians whom
patients and families always point to when they talk
about the special quality that distinguishes the care
offered by NYU physicians, for their skill, humanism and
kindness. Physicians like Richard are our very essence,
and they, like those before them, are passing an
extraordinary 172-year legacy of patient-centered care
on to the generations that follow in their footsteps.”
Those in attendance included: Saba
Bologna and Dr. William Carroll, Elisabeth Cohen, MD,
Lori and Larry Fink, Kelly Kennedy Mack and Stephen
Mack, Laura and Isaac Perlmutter, Richard Silverman,
Norma and Gordon Smith, Robin Smith, MD, PhD, Debora and
Jes Staley, and Thomas
H. Lee.
Lori Fink, chair
of the NYU Cancer Institute Advisory Board, and a
trustee of NYU Langone Medical Center since 2003, also
greeted the audience and said, “Cancer is a powerful
adversary that respects no boundaries. It can begin in
one organ and migrate anywhere; it can leap from one
bodily system to another. It takes over the lives of
patients and families. To treat it requires an even more
powerful response—and unique collaboration with
physicians and scientists across the Medical Center. How
we respond at NYU Cancer Institute—and how we
collaborate—are extraordinary: the respect between
colleagues and the relationships forged between
clinicians in the best interests of their patients. Add
to all this the supportive services we provide each
day—financial, legal, and psychological counseling,
physical therapy, acupuncture—and what you have is the
best possible care, with a ripple effect that reaches
children, parents, spouses, friends. I can’t think of a
mission I’d rather support.” In addition, Fink thanked
the NYU Cancer Advisory Board members for their
dedication, enthusiasm, and compassion.
Among the guest speakers were Suzanne Mednik and Robert
J. Friedman, MD, clinical professor, Ronald
O. Perelman Department of Dermatology.
About The Cancer
Institute NYU Langone Medical Center:
The research mission of The Cancer Institute at NYU
Langone Medical Center is to discover the origins of
cancer and use that knowledge to eradicate the personal
and societal burden of cancer in our community and
around the world. Fifteen research programs are
organized as scientific research programs, focused on
the fundamental biology of cancer in general, and as
disease-specific research programs centered on
individual types of cancer, such as breast or lung
cancer. Translational research, a hallmark of the
institute, is finding new ways to integrate the
extraordinary growth and understanding made in basic
research with the ever-growing need for the development
of new therapies and approaches in the clinic to a
variety of cancers that have remained difficult to
treat. To help translate discovery into clinical
practice, the NYU Cancer Institute has embarked on five
programs that integrate efforts in laboratory
investigation and clinical care: cancer targets and
novel therapeutics, community and environment,
integrative health, molecular oncology/cancer genomics,
and immune- and stem-cell-based therapies. The Stephen
D. Hassenfeld Children’s Center for Cancer and Blood
Disorders at The Cancer Institute is one of the nation’s
leading pediatric outpatient facilities for the
treatment of childhood cancers and blood diseases.
About NYU Langone Medical Center:
NYU Langone Medical Center, a world-class,
patient-centered, integrated academic medical center, is
one of the nation’s premier centers for excellence in
clinical care, biomedical research, and medical
education. Located in the heart of Manhattan, NYU
Langone is composed of four hospitals—Tisch Hospital,
its flagship acute care facility; Rusk Rehabilitation;
the Hospital for Joint Diseases, the Medical Center’s
dedicated inpatient orthopaedic hospital; and Hassenfeld
Pediatric Center, a comprehensive pediatric hospital
supporting a full array of children’s health services
across the Medical Center—plus the NYU School of
Medicine, which since 1841 has trained thousands of
physicians and scientists who have helped to shape the
course of medical history. The Medical Center’s tri-fold
mission to serve, teach, and discover is achieved 365
days a year through the seamless integration of a
culture devoted to excellence in patient care,
education, and research. For
more information, go to
www.NYULMC.org
and interact with us on Facebook, Twitter,
and YouTube.